本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Evoke Pharma Inc.

3.14
-0.0900-2.79%
盘后3.140.00000.00%16:00 EDT
成交量:1.16万
成交额:3.73万
市值:468.76万
市盈率:-1.12
高:3.27
开:3.24
低:3.13
收:3.23
数据加载中...
2024/02/08

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/02/07

SEC问询函

Form CORRESP - Correspondence
2024/02/07

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/17

SEC问询函

Form CORRESP - Correspondence
2024/01/16

SEC问询函

Form CORRESP - Correspondence
2024/01/16

SEC问询函

Form CORRESP - Correspondence
2024/01/11

SEC问询函

Form CORRESP - Correspondence
2024/01/11

SEC问询函

Form CORRESP - Correspondence
2024/01/11

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/05

SEC问询函

Form CORRESP - Correspondence
2024/01/05

SEC问询函

Form CORRESP - Correspondence
2024/01/04

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/19

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/29

重要事件披露

Form 8-K - Current report
2023/11/27

重要事件披露

Form 8-K - Current report
2023/11/22

重要事件披露

Form 8-K - Current report
2023/11/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]